Social media still stumps clinical trial runners; Report: Biotech's windfall means a payday for CROs;

> CROs and drug companies are still figuring out how to deal with clinical trial participants sharing information via social media. More

> Through IPOs and venture rounds, biotech companies have raised nearly $100 billion over the past 12 months, and CROs are likely in line for a sizable portion of that sum, an analyst tells Outsourcing-Pharma. Story